Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Case Report

Anadolu Psikiyatri Derg. 2020; 21(5): 557-560


Successful management of methylphenidate related thrombocytopenia during ADHD treatment: a case report

Hüsna Kaan, Ali Karayağmurlu.

Abstract
Methylphenidate is an effective and well-tolerated agent frequently used in the treatment of attention deficit hyperactivity disorder. Thrombocytopenia is defined as a blood platelet count less than 150,000/mm3 and is an important hematological side-effect capable of causing mild symptoms or severe complications such as intracranial hemorrhage. Thrombocytopenia may develop in association with various causes, including drug use. There have been very few case reports of thrombocytopenia developing during methylphenidate use, and to the best of our knowledge, there have been no reports concerning the management of this side-effect. This report describes the development of thrombocytopenia likely related to methylphenidate therapy in an adolescent with attention deficit hyperactivity disorder and successful management with a safety switch to atomoxetine

Key words: Attention Deficit Hyperactivity Disorder, Methylphenidate, Thrombocytopenia, Atomoxetine



Article Language: Turkish English


Full-text options

Full-text Article




Advertisement
American Journal of Diagnostic Imaging

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.